| 181 |
TITLE CITED BY YEAR Diagnostic and prognostic value of CD123 in acute leukemia |
2018 |
| 182 |
Vascular endothelial growth factor & basic fibroblast
growth factor polymorphism as prognostic factors in
Non-Hodgkin Lymphoma |
2018 |
| 183 |
Vascular endothelial growth factor & basic fibroblast
growth factor polymorphism as prognostic factors in
Non-Hodgkin Lymphoma |
2018 |
| 184 |
Assessment of Human Natriuretic Peptides (B), Human N-Terminal Pro-
BNP and Nor-epinephrine as Neurohumoral Markers in Sleep Disordered
Breathing among Heart Failure Patients in Upper Egypt |
2017 |
| 185 |
Assessment of inherited qualitative platelet disorders in Upper Egypt |
2017 |
| 186 |
Assessment of inherited qualitative platelet disorders in Upper Egypt |
2017 |
| 187 |
Assessment of inherited qualitative platelet disorders in Upper Egypt |
2017 |
| 188 |
B-lymphocyte stimulator: can we consider it a marker
for severity of hepatitis C virus-induced B-cell non-Hodgkin
lymphoma? |
2017 |
| 189 |
Bedside inflammatory mediators in pulmonary tuberculosis |
2017 |
| 190 |
CD30 expression versus serum soluble CD30 level as a prognostic markers in acute lymphoblastic leukemia |
2017 |